Search Result - CapitalBio Technology Co., Ltd.

All Related Products Other Content

Lab-on-a-chip Introduction
Knowledge About Transcriptome Sequencing In a broad sense, the transcriptome refers to the collection of all transcripts in a cell under a certain physiological condition, including messenger RNA, ribosomal RNA, transfer RNA and non-coding R...
Recent Advances in the Microfluidic Platform for Programming Cell-Based Biomaterials Microfluidic Platforms Promote the Development of Cell-Based Living MaterialsCell-based living materials, including single cells, cell-loaded fibers, cell sheets, organoids, and organs, have been cons...
Applications and Innovations of Microfluidic Platforms in Drug Analysis The prospects of microfluidic platforms in drug analysis applicationsThe pharmaceutical development field is now facing increasingly powerful research and development barriers and steep patent cliffs,...
About CapitalBio capitalBio Technology Co, Ltd. is the industrialized platform of capitalBio corporation and Biochip Beijing National EngineeringResearch Center and one of the core enterprises of Tsinghua University i...
Smart Health Platform The intelligent health management system provides users with precise health management.
Other Health Solutions The HLA genotyping testing laboratory of CapitalBio Technology is the first one in China with dual accreditation of ASHI and CNAS, and the largest HLA tissue matching laboratory under the China Marrow Donor Program (CMDP).
Transcriptome Sequencing Transcriptome can change with the external environment, which is different from the genome. Since thetranscriptome includes the transcription of all mRNA in cells, except for abnormal mRNA degradation...
MTB Drug Resistant Detection MDR-TB disease can be quickly diagnosed by using gene chip technology to quickly test for resistance to rifampicin and isoniazid, two of the most important first-line anti-TB drugs.
100 Loci of 18 Deafness-Related Genes Detection Using next-generation sequencing technology, it can test 100 loci in 18 deafness-related genes in humans to determine if there are mutation sites in the deafness gene.
Individualized Medication Guidance for Breast Cancer This test detects 348 genes, involves targeted therapy, immunotherapy, chemotherapy and hereditary risk assessment, and provides comprehensive medication reference for breast cancer patients.
The Disease Susceptibility Genetic Test-Esophageal Cancer This test bases on biochip technology evaluates the risk of esophageal cancer from the perspective of genetics and provide guidance on disease prevention.
CapitalBio® LuxScan™ 10K Microarray Chip Scanner Brochure
Single-cell ATAC Sequencing Capitalbio technology atac sequencing service uses the 10x genomics single-cell atac sequencing platform to detect the transposase-accessible chromatin at the single-cell level.
Pediacare Pharmacogenomics Testing

«
1 ...
6
7
8
9
10
11
12
... 21
»